Biotech investors can get ready for a busy month full of stock-moving binary events. All of these companies are waiting for the FDA to make some very important approval decisions. Here's what you should know about three of the most important approval decisions expected over the next several weeks. Read More...
Biotech investors can get ready for a busy month full of stock-moving binary events. All of these companies are waiting for the FDA to make some very important approval decisions. Here’s what you should know about three of the most important approval decisions expected over the next several weeks.
Add Comment